Impact on health‐related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate‐to‐severe atopic dermatitis
Journal article published in 2022 by
Marco Miniotti 
,
Giulia Lazzarin,
Michela Ortoncelli,
Luca Mastorino,
Simone Ribero ,
Paolo Leombruni
,
Giulia Lazzarin,
Michela Ortoncelli,
Luca Mastorino,
Simone Ribero ,
Paolo Leombruni
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 